tiprankstipranks
Trending News
More News >
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market

Cellectar Biosciences (CLRB) Financial Statements

Compare
1,438 Followers

Cellectar Biosciences Financial Overview

Cellectar Biosciences's market cap is currently $13.74M. The company's EPS TTM is $0.65; its P/E ratio is -0.59; Cellectar Biosciences is scheduled to report earnings on March 4, 2026, and the estimated EPS forecast is $-1.89. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -213.60K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -22.98M$ -51.78M$ -38.96M$ -28.81M$ -24.13M
EBITDA$ -22.77M$ -51.49M$ -38.77M$ -28.67M$ -23.98M
Net Income$ -21.79M$ -44.58M$ -42.77M$ -31.79M$ -24.12M
Balance Sheet
Cash & Short-Term Investments$ 13.20M$ 23.29M$ 9.56M$ 19.87M$ 35.70M
Total Assets$ 14.98M$ 25.47M$ 12.08M$ 21.59M$ 37.20M
Total Debt$ 409.59K$ 494.00K$ 552.98K$ 603.83K$ 301.74K
Net Debt$ -12.79M$ -22.79M$ -9.01M$ -19.26M$ -35.40M
Total Liabilities$ 5.06M$ 11.18M$ 25.85M$ 12.05M$ 4.16M
Stockholders' Equity$ 9.92M$ 14.29M$ -13.78M$ 9.54M$ 33.05M
Cash Flow
Free Cash Flow$ -23.12M$ -47.69M$ -33.24M$ -25.45M$ -22.71M
Operating Cash Flow$ -23.12M$ -47.58M$ -32.38M$ -25.22M$ -22.57M
Investing Cash Flow$ -5.88K$ -104.19K$ -864.04K$ -225.97K$ -141.36K
Financing Cash Flow$ 13.03M$ 61.41M$ 22.94M$ 9.61M$ 1.25M
Currency in USD

Cellectar Biosciences Earnings and Revenue History

Cellectar Biosciences Debt to Assets

Cellectar Biosciences Cash Flow

Cellectar Biosciences Forecast EPS vs Actual EPS